Home injections and IV infusions are often grouped under NAD+ therapy, but they are different administration experiences. A smaller appointment burden does not prove equal effects, and a longer clinic visit does not prove better results.
The useful comparison considers clinical assessment, the route prescribed, who administers treatment, and how follow-up works. If a provider claims one is stronger or more effective, ask for evidence that directly supports that comparison.
Compare the clinical and practical responsibilities of each route; do not assume equivalent outcomes.
What changes with the route
Intravenous treatment enters a vein, generally through an infusion managed by a professional. A subcutaneous injection delivers medication beneath the skin. Some products may describe other injection routes. The prescription and label must identify which route applies.
These differences can affect exposure, administration, and tolerability. Do not convert an IV protocol into home-injection directions or assume the same milligram amount is an equivalent treatment. Our label guide explains why route is an essential part of the prescription.
Supervision changes the practical responsibility
At a clinic, ask who assesses you, who administers the medicine, what monitoring occurs, and how a reaction is handled. The existence of a clinic address does not answer those questions. With home care, ask how teaching works and how you can get help when no professional is physically present.
If dexterity, vision, memory, or anxiety makes administration difficult, discuss that openly. The aim is a plan you can safely understand and follow, rather than choosing the most convenient-looking option before those needs are considered.
Time and cost need a common basis
An infusion may involve evaluation, travel, administration, and observation. Home care may involve online intake, delivery coordination, storage, and self-administration. Compare the complete routine rather than only the time the needle is in use.
Ask a clinic for the complete per-visit price and expected schedule. Ask an online service for the total prescription and support cost. The cost guide explains how to avoid comparing one infusion with an entire home supply as though they were equivalent.
The evidence does not travel automatically
The small 2019 IV pilot studied NAD-related metabolism during a six-hour infusion. It did not establish that a particular home injection produces the same changes or improves daily functioning. Nor does that pilot establish that IV treatment is the best choice for your goal.
Research must match the claim being made. The evidence guide shows how to check population, formulation, route, and outcomes without getting distracted by a dramatic headline.
Choose a conversation before a delivery method
Tell your clinician what you hope to improve and what worries you about either route. Ask whether the symptom deserves further assessment and whether a different approach has stronger evidence. There is no requirement to buy a treatment simply because you completed an intake.
If online care remains worth exploring, start with provider reviews. If in-person assessment matters, use our state directory and verify the actual local clinic. Our pages do not treat nationwide online services as local offices.
The Restore review describes a studio IM-shot model, and the Next Health review examines in-clinic IV care. The Drip Hydration review adds the distinction between a mobile appointment and a shipped self-injection kit. Each setting needs its own complete quote and practical plan.
Follow the source
References & further reading
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.